Global Biomedical Textiles Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Biomedical Textiles Market is presumed to reach the market size of nearly USD 27.51 BN by 2030 from USD 14.97 BN in 2022 with a CAGR of 7.9% under the study period of 2023 - 2030.

Biomedical textiles, also known as medical textiles or healthcare textiles, refer to specialized textile products that are designed and manufactured for use in medical and healthcare applications. These textiles are engineered to meet specific medical requirements, including biocompatibility, sterility, durability, and functionality. They play a crucial role in various medical contexts, ranging from wound care and surgical procedures to patient support and protection.

MARKET DYNAMICS:

The aging global population drives demand for biomedical textiles in wound care and orthopedics. Advances in medical technology create a need for specialized textiles to support complex procedures. Increased healthcare spending, rising chronic diseases, and infection control concerns boost demand for advanced medical textiles. Surgical textiles are crucial for maintaining sterile environments during procedures. Home healthcare demands functional textiles for patient support and wound care. Stringent regulations and standards ensure quality and safety, while the COVID-19 pandemic highlights the importance of protective textiles. Advanced wound care textiles, orthopedic applications, and eco-friendly solutions are also driving the market. Ongoing research, customization, patient comfort, and global health concerns further contribute to the expansion of the Biomedical textiles market. Overall, the market responds to evolving healthcare needs with innovative textile solutions for improved patient outcomes and safety.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biomedical textiles. The growth and trends of Biomedical Textiles Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the biomedical textiles market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Fiber Type

Non-Biodegradable Fiber
Biodegradable

By Fabric Type

Non-Woven
Woven
Others

By Application

Non-Implantable
Surgical Sutures
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Biomedical Textiles market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biomedical textiles market include Royal DSM (Netherlands) Johnson & Johnson (LIS), Medtronic (US), Cardinal Health (US) Integra deSciences Corporation (US), Smith & Nephew (UK), Medline (US) Paul Hartmann AG (Germany), and BSN Medical (Germany). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112043

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BIOMEDICAL TEXTILES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Fiber Type
- 3.7.2 Market Attractiveness Analysis By Fabric Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOMEDICAL TEXTILES MARKET ANALYSIS BY FIBER TYPE

5.1 Overview by Fiber Type
5.2 Historical and Forecast Data
5.3 Analysis by Fiber Type
5.4 Non-Biodegradable Fiber Historic and Forecast Sales by Regions
5.5 Biodegradable Historic and Forecast Sales by Regions

6 . GLOBAL BIOMEDICAL TEXTILES MARKET ANALYSIS BY FABRIC TYPE

6.1 Overview by Fabric Type
6.2 Historical and Forecast Data
6.3 Analysis by Fabric Type
6.4 Non-Woven Historic and Forecast Sales by Regions
6.5 Woven Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL BIOMEDICAL TEXTILES MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Non-Implantable Historic and Forecast Sales by Regions
7.5 Surgical Sutures Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BIOMEDICAL TEXTILES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BIOMEDICAL TEXTILES COMPANIES

9.1. Biomedical Textiles Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BIOMEDICAL TEXTILES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Royal DSM (Netherlands)
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Johnson & Johnson (LIS)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Medtronic (US)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Cardinal Health (US)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Integra deSciences Corporation (US)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Smith & Nephew (UK)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Medline (US)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Paul Hartmann AG (Germany)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. BSN Medical (Germany)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies